TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive NCI advisors approved in concept the Institute’s plan to spend $24 million over five years for research on “patient navigator” programs. March 26, 2004
TCL Archive NCI Advisors Approve $20.5M Program Of Grants, Contracts For Biospecimen Research. July 6, 2007
TCL Archive Another Feasibility Study For Women’s Wealth Trial? Yes And No; It’s ‘Class Of 84’s” Adieu December 14, 1990
TCL Archive NCAB Subcommittee Calls For Review Of Organ Site Program, Consideration Of One For Lung Cancer May 1, 1981
